Citadel Advisors’s Red Violet RDVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414K Buy
+6,500
New +$308K ﹤0.01% 10331
2026
Q1
Sell
-11,300
Closed -$644K 14013
2025
Q4
$644K Buy
+11,300
New +$613K ﹤0.01% 8407
2025
Q1
Sell
-4,800
Closed -$174K 15388
2024
Q4
$174K Buy
4,800
+1,700
+55% +$56.6K ﹤0.01% 10671
2024
Q3
$88.2K Buy
3,100
+1,700
+121% +$46.1K ﹤0.01% 11284
2024
Q2
$35.6K Buy
1,400
+1,000
+250% +$20.2K ﹤0.01% 12105
2024
Q1
$7.82K Hold
400
﹤0.01% 13593
2023
Q4
$7.99K Sell
400
-1,400
-78% -$27.9K ﹤0.01% 13254
2023
Q3
$36K Buy
1,800
+400
+29% +$8.28K ﹤0.01% 12129
2023
Q2
$28.8K Buy
+1,400
New +$26.1K ﹤0.01% 12397

Other funds holding RDVT

Citadel Advisors's RDVT Position: Q2 2026 in Review

Citadel Advisors reduced its Red Violet (RDVT) stake by 6.4% in Q2 2026, selling an estimated $166K and leaving 50,914 shares worth $3.24M. The position accounts for ﹤0.01% of the portfolio, ranked #5545.

Citadel Advisors first reported a position in RDVT in Q1 2018 and has held it in 20 quarters since. The position peaked at $3.62M in Q2 2025. 173 funds tracked by Wall St. Rank hold RDVT as of Q2 2026.

  • Citadel Advisors held 50,914 shares of Red Violet worth $3.24M as of Q2 2026.
  • Citadel Advisors sold 3,504 Red Violet shares in Q2 2026, an estimated $166K.
  • Red Violet made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #5545 holding.
  • Citadel Advisors first reported a position in Red Violet in Q1 2018 and has held it in 20 quarters since.
  • Citadel Advisors's Red Violet position peaked at $3.62M in Q2 2025.
  • 173 funds tracked by Wall St. Rank held Red Violet as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.